State Street Corp Electro Core, Inc. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.26 - $5.54 $44,746 - $953,434	-172,100 Closed	0 $0
Q2 2022 Aug 15, 2022	BUY	$0.27 - $0.61 $2,052 - $4,636	7,600 Added 4.62%	172,100 $88,000
Q4 2021 Feb 14, 2022	BUY	$0.58 - $1.09 $31,493 - $59,187	54,300 Added 49.27%	164,500 $96,000
Q2 2021 Aug 16, 2021	BUY	$1.19 - $2.06 $131,138 - $227,012	110,200 New	110,200 $131,000
Q2 2020 Aug 14, 2020	SELL	$0.75 - $1.29 $196,608 - $338,165	-262,144 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$0.33 - $1.62 $86,507 - $424,673	262,144 New	262,144 $249,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $503M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.